Prathipati P, Pathania A, Chaturvedi N, Gupta S, Byrareddy S, Coulter D
Mol Ther Nucleic Acids. 2024; 35(2):101543.
PMID: 38817681
PMC: 11137595.
DOI: 10.1016/j.omtn.2022.03.014.
Yoneda A
Pediatr Surg Int. 2023; 39(1):177.
PMID: 37039977
DOI: 10.1007/s00383-023-05459-1.
Takita J
JMA J. 2021; 4(4):321-331.
PMID: 34796286
PMC: 8580727.
DOI: 10.31662/jmaj.2021-0077.
Mullen C, Barr R, Franco E
Br J Cancer. 2021; 125(12):1612-1620.
PMID: 34471259
PMC: 8651632.
DOI: 10.1038/s41416-021-01533-4.
Woods W
JNCI Cancer Spectr. 2021; 5(4).
PMID: 34240007
PMC: 8259618.
DOI: 10.1093/jncics/pkab042.
Neuroblastoma Screening at 1 Year of Age: The Final Results of a Controlled Trial.
Berthold F, Spix C, Erttmann R, Hero B, Michaelis J, Treuner J
JNCI Cancer Spectr. 2021; 5(4).
PMID: 34240006
PMC: 8259619.
DOI: 10.1093/jncics/pkab041.
Retinoblastoma and Neuroblastoma Predisposition and Surveillance.
Kamihara J, Bourdeaut F, Foulkes W, Molenaar J, Mosse Y, Nakagawara A
Clin Cancer Res. 2017; 23(13):e98-e106.
PMID: 28674118
PMC: 7266051.
DOI: 10.1158/1078-0432.CCR-17-0652.
Serum-Based Quantification of MYCN Gene Amplification in Young Patients with Neuroblastoma: Potential Utility as a Surrogate Biomarker for Neuroblastoma.
Yagyu S, Iehara T, Tanaka S, Gotoh T, Misawa-Furihata A, Sugimoto T
PLoS One. 2016; 11(8):e0161039.
PMID: 27513929
PMC: 4981470.
DOI: 10.1371/journal.pone.0161039.
Imaging in neuroblastoma: An update.
Kembhavi S, Shah S, Rangarajan V, Qureshi S, Popat P, Kurkure P
Indian J Radiol Imaging. 2015; 25(2):129-36.
PMID: 25969636
PMC: 4419422.
DOI: 10.4103/0971-3026.155844.
Effectiveness of nationwide screening program for neuroblastoma in Japan.
Hisashige A
Glob J Health Sci. 2014; 6(4):94-106.
PMID: 25001552
PMC: 4825238.
DOI: 10.5539/gjhs.v6n4p94.
Genetic lineages of undifferentiated-type gastric carcinomas analysed by unsupervised clustering of genomic DNA microarray data.
Sonoda A, Mukaisho K, Nakayama T, Diem V, Hattori T, Andoh A
BMC Med Genomics. 2013; 6:25.
PMID: 23866769
PMC: 3728264.
DOI: 10.1186/1755-8794-6-25.
Dependence receptor UNC5D mediates nerve growth factor depletion-induced neuroblastoma regression.
Zhu Y, Li Y, Haraguchi S, Yu M, Ohira M, Ozaki T
J Clin Invest. 2013; 123(7):2935-47.
PMID: 23778138
PMC: 3696554.
DOI: 10.1172/JCI65988.
Long-term follow-up of the "wait and see" approach to localized perinatal adrenal neuroblastoma.
Cozzi D, Mele E, Ceccanti S, Natale F, Clerico A, Schiavetti A
World J Surg. 2012; 37(2):459-65.
PMID: 23135423
DOI: 10.1007/s00268-012-1837-0.
Successful treatment of infants with localized neuroblastoma based on their MYCN status.
Iehara T, Hamazaki M, Tajiri T, Kawano Y, Kaneko M, Ikeda H
Int J Clin Oncol. 2012; 18(3):389-95.
PMID: 22383024
DOI: 10.1007/s10147-012-0391-y.
Autoantibody signature differentiates Wilms tumor patients from neuroblastoma patients.
Schmitt J, Keller A, Nourkami-Tutdibi N, Heisel S, Habel N, Leidinger P
PLoS One. 2011; 6(12):e28951.
PMID: 22194956
PMC: 3241697.
DOI: 10.1371/journal.pone.0028951.
Clinical presentations and imaging findings of neuroblastoma beyond abdominal mass and a review of imaging algorithm.
Chu C, Rasalkar D, Hu Y, Cheng F, Li C, Chu W
Br J Radiol. 2010; 84(997):81-91.
PMID: 21172969
PMC: 3473807.
DOI: 10.1259/bjr/31861984.
Lineage analysis of early and advanced tubular adenocarcinomas of the stomach: continuous or discontinuous?.
Nakayama T, Ling Z, Mukaisho K, Hattori T, Sugihara H
BMC Cancer. 2010; 10:311.
PMID: 20565940
PMC: 2898698.
DOI: 10.1186/1471-2407-10-311.
Distinct transcriptional MYCN/c-MYC activities are associated with spontaneous regression or malignant progression in neuroblastomas.
Westermann F, Muth D, Benner A, Bauer T, Henrich K, Oberthuer A
Genome Biol. 2008; 9(10):R150.
PMID: 18851746
PMC: 2760877.
DOI: 10.1186/gb-2008-9-10-r150.
MYCN gene amplification is a powerful prognostic factor even in infantile neuroblastoma detected by mass screening.
Iehara T, Hosoi H, Akazawa K, Matsumoto Y, Yamamoto K, Suita S
Br J Cancer. 2006; 94(10):1510-5.
PMID: 16670717
PMC: 2361271.
DOI: 10.1038/sj.bjc.6603149.
Clinical significance of serum NM23-H1 protein in neuroblastoma.
Okabe-Kado J, Kasukabe T, Honma Y, Hanada R, Nakagawara A, Kaneko Y
Cancer Sci. 2005; 96(10):653-60.
PMID: 16232196
PMC: 11158868.
DOI: 10.1111/j.1349-7006.2005.00091.x.
